OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmacological Reports is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Drug repurposing approach to fight COVID-19	305
Drug resistance in cancer: mechanisms and tackling strategies	120
Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials	81
Overview of the possible role of vitamin C in management of COVID-19	77
Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19	68
Chemotherapy-induced peripheral neuropathy: part 1—current state of knowledge and perspectives for pharmacotherapy	68
Role of oxidative stress in epileptogenesis and potential implications for therapy	61
Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity	61
Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes	58
Thiadiazole derivatives as anticancer agents	50
Pharmacological properties of baicalin on liver diseases: a narrative review	49
Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms	47
Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention	46
Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis	44
In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis	44
Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future	43
Recent review of COVID-19 management: diagnosis, treatment and vaccination	40
Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance	39
Effects of curcumin on neurological diseases: focus on astrocytes	39
Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies	38
Neurotoxic effects of aluminium exposure as a potential risk factor for Alzheimer’s disease	37
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial	36
Efflux pump inhibitors: new updates	36
A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome	34
STAT3 transcription factor as target for anti-cancer therapy	33

Pharmacological treatments of COVID-19	33
Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison	31
Mechanistic insight on the role of leukotriene receptors in ischemic–reperfusion injury	31
Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a theoretical perspective	30
Oral antiviral treatments for COVID-19: opportunities and challenges	30
Observational study of people infected with SARS-Cov-2, treated with amantadine	30
Effects and mechanisms of phthalates’ action on neurological processes and neural health: a literature review	30